English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) is pleased to announce that Sabrina Reilly has been named chief membership and market development officer for the organization, effective today.
Tag: Association for Diagnostics & Laboratory Medicine
Association for Diagnostics & Laboratory Medicine (formerly AACC) files an amicus brief backing the American Clinical Laboratory Association’s lawsuit against the FDA
Today, the Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC), together with the American Association of Bioanalysts, American Society for Clinical Pathology, American Society for Microbiology, and the Infectious Disease Society of America, has filed an amicus brief in the case of American Clinical Laboratory Association (ACLA), et al. v. U.S. Food and Drug Administration (FDA), et al.
ADLM publishes new guidance on lipid testing to improve care for patients with cardiovascular disease
The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) has issued expert guidance on lipid tests, which measure blood levels of fats and cholesterol to help assess a patient’s risk of heart disease and stroke. By giving clinicians and laboratory medicine professionals much-needed clarity on how to best use these tests, the new guidelines will ensure that more patients with cardiovascular disease get the treatment they need.
Expert insights on laboratory developed tests, the consequences of ending abortion protection, health equity, and more draw 18,000 attendees to ADLM 2024
The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC), welcomed thousands of laboratory experts to ADLM 2024 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo) from July 28-August 1. The meeting featured groundbreaking advances in diagnostic research and technology that exemplify the essential role that the field of laboratory medicine plays in patient care.
New research shows how machine learning could revolutionize diagnosis and treatment of multiple myeloma and sepsis
Exciting research at the frontier of artificial intelligence and data science in laboratory medicine was presented today at ADLM 2024 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo).
New test can detect patients’ risk of harmful side effects from Alzheimer’s drugs
Today at ADLM 2024 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo), researchers will present data on a novel test that predicts whether Alzheimer’s patients are genetically predisposed to side effects from anti-amyloid drugs, a promising new class of Alzheimer’s therapeutics.
Novel study reveals that a surprising number of pregnant people are using cannabis — and need to be informed of its risks
Breaking research shows that rates of cannabis use during pregnancy are far higher than previously thought, a finding that could improve efforts to identify pregnant cannabis users and inform them of potential risks.
Breaking research on the use of race in prenatal screens, health outcomes of HIV-exposed children could advance healthcare for underserved populations
In a new study, researchers have demonstrated that there is an insufficient basis for incorporating race in prenatal screening for birth defects. In a second, separate study, researchers have found that HIV-exposed uninfected children are at higher risk for health problems compared to uninfected, unexposed children.
ADLM announces 2024 Top Corporate Supporter Award recipients and thanks them for their vital backing
The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) is pleased to announce the recipients of its 2024 Top Corporate Supporter Award, a distinction given to companies and organizations that generously support the association through advertising, sponsorships, and exhibits.
The consequences of ending abortion protection, the patient perspective on laboratory developed tests, health equity, and more to be explored at ADLM 2024
At ADLM 2024 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo) in Chicago, more than 300 experts will present cutting-edge research and technology that will shape the future of laboratory medicine and improve patient care.
Association for Diagnostics & Laboratory Medicine (formerly AACC) honors Representatives John Joyce, MD, and Cathy McMorris Rodgers for their commitment to ensuring that patients have access to high quality clinical tests
The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) is pleased to announce that Representatives John Joyce, MD (R-Pa.), and Cathy McMorris Rodgers (R-Wash.) are the recipients of ADLM’s Outstanding Legislator Awards for the 118th Congress.
Association for Diagnostics & Laboratory Medicine (formerly AACC) survey finds that FDA’s final laboratory developed tests rule will impede the fight against the U.S.’s drug epidemic
Today, the Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) released the results of a survey that ADLM conducted to determine how the Food and Drug Administration’s (FDA’s) final laboratory developed tests rule will impact patient access to essential tests. The survey found that, in spite of certain tests being exempt from the rule, it will still force many laboratories, particularly those in hospitals, to discontinue critical tests, including those needed to identify prescription and illegal drug use.
MEDIA ADVISORY – Webinar: The U.S. FDA’s rule on LDTs – What it means for you
The U.S. Food and Drug Administration (FDA) has long sparked controversy with its proposals to regulate laboratory developed tests (LDTs) as medical devices.
Strategies Behind Near-Zero COVID-19 Incidence in NBA “Bubble” Published in ADLM’s The Journal of Applied Laboratory Medicine
A report published today in the Association for Diagnostics & Laboratory Medicine’s (formerly AACC’s) The Journal of Applied Laboratory Medicine describes the strategies used by the National Basketball Association (NBA) to limit COVID-19 exposure among the individuals who participated in the 2019–2020 season. The success of the NBA’s approach demonstrates that strict adherence to certain protocols can be highly effective in preventing disease outbreaks in a self-contained environment and serves as a model for future pandemic management.